vs
Side-by-side financial comparison of AVALON HOLDINGS CORP (AWX) and Xilio Therapeutics, Inc. (XLO). Click either name above to swap in a different company.
AVALON HOLDINGS CORP is the larger business by last-quarter revenue ($21.5M vs $13.7M, roughly 1.6× Xilio Therapeutics, Inc.). Xilio Therapeutics, Inc. runs the higher net margin — 75.7% vs -1.7%, a 77.4% gap on every dollar of revenue. AVALON HOLDINGS CORP produced more free cash flow last quarter ($-166.0K vs $-2.1M).
Avalon Hill Games Inc. is a game company that publishes wargames and strategic board games. It has also published miniature wargaming rules, role-playing games and sports simulations. It is a subsidiary of Hasbro, and operates under the company's "Hasbro Gaming" division.
Xilio Therapeutics is a clinical-stage biotechnology company dedicated to developing novel tumor-selective immunotherapies for cancer treatment. Its product pipeline features candidates engineered to trigger anti-tumor immune responses specifically inside tumor microenvironments, reducing systemic toxicities, and it primarily targets oncology patient populations in North America and other global markets.
AWX vs XLO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.5M | $13.7M |
| Net Profit | $-356.0K | $10.4M |
| Gross Margin | 17.1% | — |
| Operating Margin | 0.4% | -86.5% |
| Net Margin | -1.7% | 75.7% |
| Revenue YoY | 21.7% | — |
| Net Profit YoY | 28.4% | 179.1% |
| EPS (diluted) | — | $-3.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.5M | $13.7M | ||
| Q3 25 | $25.7M | $19.1M | ||
| Q2 25 | $20.3M | $8.1M | ||
| Q1 25 | $16.1M | $2.9M | ||
| Q4 24 | $17.6M | — | ||
| Q3 24 | $24.2M | — | ||
| Q2 24 | $23.1M | — | ||
| Q1 24 | $18.9M | — |
| Q4 25 | $-356.0K | $10.4M | ||
| Q3 25 | $1.9M | $-16.3M | ||
| Q2 25 | $274.0K | $-15.8M | ||
| Q1 25 | $-1.5M | $-13.3M | ||
| Q4 24 | $-497.0K | — | ||
| Q3 24 | $1.8M | — | ||
| Q2 24 | $954.0K | — | ||
| Q1 24 | $-979.0K | — |
| Q4 25 | 17.1% | — | ||
| Q3 25 | 23.7% | — | ||
| Q2 25 | 20.6% | — | ||
| Q1 25 | 14.8% | — | ||
| Q4 24 | 17.5% | — | ||
| Q3 24 | 24.6% | — | ||
| Q2 24 | 22.1% | — | ||
| Q1 24 | 16.2% | — |
| Q4 25 | 0.4% | -86.5% | ||
| Q3 25 | 9.1% | -10.1% | ||
| Q2 25 | 3.7% | -177.7% | ||
| Q1 25 | -7.2% | -472.7% | ||
| Q4 24 | -0.8% | — | ||
| Q3 24 | 9.4% | — | ||
| Q2 24 | 6.3% | — | ||
| Q1 24 | -2.7% | — |
| Q4 25 | -1.7% | 75.7% | ||
| Q3 25 | 7.4% | -85.4% | ||
| Q2 25 | 1.4% | -196.0% | ||
| Q1 25 | -9.3% | -452.7% | ||
| Q4 24 | -2.8% | — | ||
| Q3 24 | 7.6% | — | ||
| Q2 24 | 4.1% | — | ||
| Q1 24 | -5.2% | — |
| Q4 25 | — | $-3.74 | ||
| Q3 25 | — | $-0.11 | ||
| Q2 25 | — | $-0.16 | ||
| Q1 25 | — | $-0.18 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $38.4M | $35.3M |
| Total Assets | $87.4M | $154.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | $137.5M | ||
| Q3 25 | $4.6M | $103.8M | ||
| Q2 25 | $3.7M | $121.6M | ||
| Q1 25 | $1.3M | $89.1M | ||
| Q4 24 | $2.8M | — | ||
| Q3 24 | $3.9M | — | ||
| Q2 24 | $3.8M | — | ||
| Q1 24 | $1.2M | — |
| Q4 25 | $38.4M | $35.3M | ||
| Q3 25 | $38.7M | $-8.1M | ||
| Q2 25 | $36.8M | $7.1M | ||
| Q1 25 | $36.5M | $10.7M | ||
| Q4 24 | $38.0M | — | ||
| Q3 24 | $38.5M | — | ||
| Q2 24 | $36.7M | — | ||
| Q1 24 | $35.7M | — |
| Q4 25 | $87.4M | $154.7M | ||
| Q3 25 | $90.7M | $133.7M | ||
| Q2 25 | $88.1M | $133.8M | ||
| Q1 25 | $87.6M | $103.7M | ||
| Q4 24 | $86.2M | — | ||
| Q3 24 | $89.1M | — | ||
| Q2 24 | $91.7M | — | ||
| Q1 24 | $90.6M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $278.0K | $-2.0M |
| Free Cash FlowOCF − Capex | $-166.0K | $-2.1M |
| FCF MarginFCF / Revenue | -0.8% | -15.3% |
| Capex IntensityCapex / Revenue | 2.1% | 0.7% |
| Cash ConversionOCF / Net Profit | — | -0.19× |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $278.0K | $-2.0M | ||
| Q3 25 | $1.5M | $-17.5M | ||
| Q2 25 | $3.0M | $-14.5M | ||
| Q1 25 | $-982.0K | $29.0M | ||
| Q4 24 | $-579.0K | — | ||
| Q3 24 | $342.0K | — | ||
| Q2 24 | $3.2M | — | ||
| Q1 24 | $411.0K | — |
| Q4 25 | $-166.0K | $-2.1M | ||
| Q3 25 | $852.0K | — | ||
| Q2 25 | $2.7M | $-14.9M | ||
| Q1 25 | $-1.4M | $29.0M | ||
| Q4 24 | $-1.1M | — | ||
| Q3 24 | $-660.0K | — | ||
| Q2 24 | $2.9M | — | ||
| Q1 24 | $56.0K | — |
| Q4 25 | -0.8% | -15.3% | ||
| Q3 25 | 3.3% | — | ||
| Q2 25 | 13.5% | -184.0% | ||
| Q1 25 | -8.5% | 988.3% | ||
| Q4 24 | -6.4% | — | ||
| Q3 24 | -2.7% | — | ||
| Q2 24 | 12.4% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | 2.1% | 0.7% | ||
| Q3 25 | 2.3% | 0.0% | ||
| Q2 25 | 1.4% | 5.0% | ||
| Q1 25 | 2.4% | 0.8% | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.9% | — |
| Q4 25 | — | -0.19× | ||
| Q3 25 | 0.76× | — | ||
| Q2 25 | 11.07× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 3.35× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
